SABCS: Long-term outcomes good for PBI in early breast cancer

(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study prese

Updated on: December 22,2023

SABCS: Long-term outcomes good for PBI in early breast cancer

(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study prese

Updated on:December 22,2023

Viagra could help treat oxygen-deprived newborns, clinical trial finds

by McGill University Health CentreEvolution over time of brain MRI of 2 neonates with NE with severe near-total brain injury despite TH, when treated with TH and placebo (top) and when treated wi

Updated on: May 26,2024

Viagra could help treat oxygen-deprived newborns, clinical trial finds

by McGill University Health CentreEvolution over time of brain MRI of 2 neonates with NE with severe near-total brain injury despite TH, when treated with TH and placebo (top) and when treated wi

Updated on:May 26,2024

Study reveals mechanism involved in rare pediatric brain cancer and points to possible treatment

by André Julião,FAPESPThe study focused on supratentorial ependymoma with fusion of the genes C11orf95 and RELA [ST-RELA], a sub-group frequent in children. Credit: Taciani MagalhãesA study cond

Updated on: January 28,2024

Study reveals mechanism involved in rare pediatric brain cancer and points to possible treatment

by André Julião,FAPESPThe study focused on supratentorial ependymoma with fusion of the genes C11orf95 and RELA [ST-RELA], a sub-group frequent in children. Credit: Taciani MagalhãesA study cond

Updated on:January 28,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European

Updated on: December 18,2023

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European

Updated on:December 18,2023

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on: September 15,2025

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on:September 15,2025

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on: December 23,2023

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on:December 23,2023

Cellular 'fingerprint' may offer early warning of cancer risk

by Isabella Backman,Yale UniversityCellDRIFT is turned back upon reprogramming in human fibroblasts, but is not stabilized with additional passages. (A) Scatterplot showing reprogramming traject

Updated on: January 10,2024

Cellular 'fingerprint' may offer early warning of cancer risk

by Isabella Backman,Yale UniversityCellDRIFT is turned back upon reprogramming in human fibroblasts, but is not stabilized with additional passages. (A) Scatterplot showing reprogramming traject

Updated on:January 10,2024

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainImmunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identif

Updated on: January 25,2024

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainImmunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identif

Updated on:January 25,2024

Diagnosis of ovarian cancer delayed by woeful lack of awareness

by World Ovarian Cancer CoalitionA global study of women with ovarian cancer has found that two thirds of women had never heard of the disease, or did not know anything about it before their diagnosis

Updated on: December 18,2023

Diagnosis of ovarian cancer delayed by woeful lack of awareness

by World Ovarian Cancer CoalitionA global study of women with ovarian cancer has found that two thirds of women had never heard of the disease, or did not know anything about it before their diagnosis

Updated on:December 18,2023

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on: February 20,2024

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on:February 20,2024

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on: August 27,2024

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on:August 27,2024